Larry W Kwak (Larry Kwak)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Nature communications

Research square

Leukemia

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottam, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C Lee, Elisabet E Manasanch, Sattva S Neelapu, Larry W Kwak, Sheeba K Thomas
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial. Nature communications 15 (1) (2024)
Larry W Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottham, Sheetal Rao, Jasper Olsem, Brandon Crumpton, Hans C Lee, Elisabet Manasanch, Sattva S Neelapu, Sheeba Thomas
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. Research square (2023)
Muzaffar H Qazilbash, Larry W Kwak
Personalized Medicine's Coming of Age: One Drug, One Patient. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Xiuli Wang, Zhenyuan Dong, Dennis Awuah, Wen-Chung Chang, Wesley A Cheng, Vibhuti Vyas, Soung-Chul Cha, Aaron J Anderson, Tiantian Zhang, Zhe Wang, Szymon J Szymura, Benjamin Z Kuang, Mary C Clark, Ibrahim Aldoss, Stephen J Forman, Larry W Kwak, Hong Qin
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia. Leukemia 36 (4) (2022)
Hong Qin, Zhenyuan Dong, Xiuli Wang, Wesley A Cheng, Feng Wen, Weili Xue, Han Sun, Miriam Walter, Guowei Wei, D Lynne Smith, Xiuhua Sun, Fan Fei, Jianming Xie, Theano I Panagopoulou, Chun-Wei David Chen, Joo Y Song, Ibrahim Aldoss, Clarisse Kayembe, Luisa Sarno, Markus Müschen, Giorgio G Inghirami, Stephen J Forman, Larry W Kwak
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies. Science translational medicine 11 (511) (2020)

Larry W Kwak.css-eqlu8i{font-size:small;padding-left:4px;} (Larry Kwak)

Publication Activity (10 Years)

Top Topics

Top Venues

Larry W Kwak (Larry Kwak)